Literature DB >> 22892482

Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature.

Xin-Pu Miao1, Xiao-Ning Sun, Hong Wei, Qin Ouyang.   

Abstract

The comorbidity of Crohn's disease (CD) and primary sclerosing cholangitis (PSC) is uncommon. Diagnosing such patients can be difficult, as illustrated by the following case. The combination of CD and PSC should be considered in patients with CD who have abnormal liver function. Because patients with PSC often present asymptomatically, all patients with CD should be screened for PSC by checking serum liver tests. Review of the literature suggests that there is an increased potential in these patients for the development of malignancy and long-term prognosis is poor. We conclude that patients diagnosed with a combination of CD and PSC should be managed with periodic colonoscopy, CA 19-9 investigation, early liver and bowel imaging, and liver biopsy. The treatment of CD associated with PSC remains unsatisfactory and the possibility of liver transplantation should be considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892482     DOI: 10.2169/internalmedicine.51.7583

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Rapid progression of primary sclerosing cholangitis complicated with ulcerative colitis.

Authors:  Piotr Pardak; Ewa Walczak; Rafał S Filip
Journal:  Case Rep Gastrointest Med       Date:  2015-01-28

2.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

3.  Evans syndrome in a young man with rare autoimmune associations and transplanted liver.

Authors:  Matthew Dominic McCarthy; A G Mohamed Fareeth
Journal:  BMJ Case Rep       Date:  2022-09-28

4.  Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study.

Authors:  Xian-Rui Wu; Xiao-Bin Zheng; Yan Huang; Qian Cao; Hong-Jie Zhang; Ying-Lei Miao; Kai-Fang Zou; Min Chen; Fa-Ming Zhang; Qiao Mei; David Gonzalo; Daniela Allende; Pin-Jin Hu; Bo Shen; Xiu-Li Liu; Ping Lan
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.